{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:21:44Z","timestamp":1768407704171,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bbrc.2017.03.084","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T21:02:46Z","timestamp":1489870966000},"page":"551-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR"],"prefix":"10.1016","volume":"486","author":[{"given":"Yuka","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Kyogashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinoti","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Murate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.03.084_bib1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbrc.2017.03.084_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-8588(05)70230-6","article-title":"Paclitaxel and docetaxel in prostate cancer","volume":"15","author":"Obasaju","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.bbrc.2017.03.084_bib3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.03.084_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1083\/jcb.147.3.545","article-title":"Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival","volume":"147","author":"Olivera","year":"1999","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00210-007-0132-3","article-title":"Regulation and functional roles of sphingosine kinases","volume":"374","author":"Alemany","year":"2007","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.bbrc.2017.03.084_bib7","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1194\/jlr.R800065-JLR200","article-title":"Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling","volume":"50","author":"Maceyka","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2017.03.084_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/138945008785132402","article-title":"Targeting SphK1 as a new strategy against cancer","volume":"9","author":"Shida","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbrc.2017.03.084_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbior.2015.09.001","article-title":"Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation","volume":"60","author":"Pyne","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbrc.2017.03.084_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.2007.04673.x","article-title":"RET signaling-induced SPHK1 gene expression plays a role in both GDNF-induced differentiation and MEN2-type oncogenesis","volume":"102","author":"Murakami","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0960-9822(00)00834-4","article-title":"An oncogenic role of sphingosine kinase","volume":"10","author":"Xia","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib12","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood-2004-12-4832","article-title":"Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression","volume":"106","author":"Le Scolan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.03.084_bib13","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.leu.2404386","article-title":"Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes","volume":"20","author":"Sobue","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2017.03.084_bib14","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1074\/jbc.M900735200","article-title":"Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation","volume":"284","author":"Nemoto","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12185-008-0052-0","article-title":"Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells","volume":"87","author":"Sobue","year":"2008","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1096\/fj.05-4331fje","article-title":"Sphingosine kinase 1 is up-regulated in colon carcinogenesis","volume":"20","author":"Kawamori","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2017.03.084_bib17","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1158\/0008-5472.CAN-05-2702","article-title":"Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models","volume":"65","author":"Pchejetski","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.03.084_bib18","first-page":"113","article-title":"Sphingosine kinase: biochemical and cellular regulation and role in disease","volume":"39","author":"Taha","year":"2006","journal-title":"J.\u00a0Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagrm.2009.08.006","article-title":"Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin","volume":"1789","author":"Ito","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.03.084_bib20","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1074\/jbc.M111594200","article-title":"Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line","volume":"277","author":"Murate","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jb\/mvs037","article-title":"Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer cell line, MCF-7","volume":"151","author":"Ito","year":"2012","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib22","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1158\/0008-5472.CAN-09-2198","article-title":"Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2\/Bcl-xL upregulation","volume":"69","author":"Colie","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.03.084_bib23","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1096\/fj.10-180190","article-title":"Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis","volume":"25","author":"Huang","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2017.03.084_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/EC.3.3.795-805.2004","article-title":"Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs","volume":"3","author":"Min","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.bbrc.2017.03.084_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2016.09.128","article-title":"Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel","volume":"479","author":"Sobue","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.03.084_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cyto.2013.06.313","article-title":"CCR1\/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2\/9 and by activating ERK and Rac signaling","volume":"64","author":"Kato","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2017.03.084_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbagrm.2014.02.004","article-title":"Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines","volume":"1839","author":"Nishida","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.03.084_bib28","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/jcb.25173","article-title":"Increased SPHK2 transcription of human colon cancer cells in serum-depleted culture: the involvement of CREB transcription factor","volume":"116","author":"Mizutani","year":"2015","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jb\/mvs033","article-title":"Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells","volume":"151","author":"Tanaka","year":"2012","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbamcr.2013.01.001","article-title":"Sphingosine kinase 1 expression is downregulated during differentiation of Friend cells due to decreased c-MYB","volume":"1833","author":"Mizutani","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.03.084_bib31","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1021\/jm4011687","article-title":"Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors","volume":"57","author":"Plano","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2017.03.084_bib32","first-page":"910","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.bbrc.2017.03.084_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","article-title":"Revisiting the sphingolipid rheostat: evolving concepts in cancer therapy","volume":"333","author":"Newton","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2017.03.084_bib34","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbrc.2006.02.070","article-title":"High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation","volume":"342","author":"Akao","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.03.084_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/cgt.2016.71","article-title":"Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes","volume":"23","author":"Mezencev","year":"2016","journal-title":"Cancer Gene Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17305508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17305508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T22:57:11Z","timestamp":1568933831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17305508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0006291X17305508"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.084","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}